| Patents for C07J 11 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3 (283) |
|---|
| 07/02/2002 | CA2064478C Ophthalmic composition |
| 06/20/2002 | WO2002026759A3 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/12/2002 | EP1212345A2 Orally active 7.alpha.-alkyl androgens |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | CA2422056A1 17.alpha. fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 01/17/2002 | US20020007079 Meiosis regulating compounds |
| 11/27/2001 | US6323191 Generation of chloride secretion from epithelial cells |
| 10/02/2001 | US6297228 Use of angiostatic steroids in photodynamic therapy |
| 09/05/2001 | CN1311792A Meiosis regulating compound |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 04/04/2001 | EP1087988A1 Meiosis regulating compounds |
| 03/28/2001 | EP1085878A2 Use of aminosterol derivatives as chloride ionophores |
| 02/15/2001 | WO2000059920A3 Orally active 7.alpha.-alkyl androgens |
| 01/02/2001 | CA2194221C Cationic amphiphiles |
| 10/12/2000 | WO2000059920A2 Orally active 7.alpha.-alkyl androgens |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 07/18/2000 | US6090957 Process for preparing neuromuscular blocking agents and intermediates useful therefor |
| 05/31/2000 | EP1003553A1 The use of angiostatic steroids in photodynamic therapy |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/13/2000 | WO1999065462A3 Use of aminosterol derivatives as chloride ionphores |
| 03/14/2000 | US6037339 C-11 substituted steroids for treating menopausal complaints |
| 02/03/2000 | WO2000005242A1 Dehydroepiandrosterone derivatives for prophylaxis and treatment of osteoporosis |
| 12/29/1999 | WO1999067273A1 Meiosis regulating compounds |
| 12/29/1999 | CA2335329A1 Meiosis regulating compounds |
| 12/23/1999 | WO1999065462A2 Use of aminosterol derivatives as chloride ionphores |
| 12/23/1999 | CA2334805A1 Use of aminosterol derivatives as chloride ionphores |
| 11/24/1999 | CN1046735C Steroids for treating menopausal complaints |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 01/28/1999 | WO1999003503A1 The use of angiostatic steroids in photodynamic therapy |
| 01/28/1999 | CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization |
| 11/03/1998 | US5831104 Steroid intermediate products and method of their production |
| 10/06/1998 | US5817803 Androsterone derivatives |
| 09/15/1998 | US5808051 Process for preparing neuromuscular blocking agents and intermediates useful therefor |
| 09/08/1998 | US5804576 Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
| 06/23/1998 | US5770592 Vision defects |
| 04/28/1998 | US5744462 Administering glucose-6-phosphate dehydrogenase inhibitor |
| 02/03/1998 | US5714481 Administering to mammalian host a glucose-6-phsophate dehydrogenase inhibitor, anticarcinogenic, antiobasity, anti-hyperglycemic, antiaging, anticholesterol and anti-autoimmune agent |
| 01/28/1998 | EP0489779B1 Ophthalmic composition |
| 01/20/1998 | US5710144 Osteoporosis |
| 12/31/1997 | CN1036835C Method for prepn. of multiple step combination type contraceptive |
| 12/31/1997 | CN1036834C Method for prepn. of contraceptive |
| 12/31/1997 | CN1036833C Method for prepn. of multiple step contraceptive |
| 12/23/1997 | US5700793 An androstane-17-one and ene steroids; hypoglycemic agent, anticholesterol agent; treating autoimmune diseases |
| 12/17/1997 | CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position |
| 12/16/1997 | US5698545 Angiostatic steroids and methods and compositions for controlling ocular hypertension |
| 12/09/1997 | US5696106 Steroids useful as anti-cancer and anti-obesity agents |
| 11/19/1997 | EP0807116A1 Cationic amphiphiles |
| 10/21/1997 | US5679666 Administering topically, systemically or intraocularly to a host steroids selected from pregnadien derivatives, hydroxyprogesterone and tetrahydrocortexolone |
| 08/12/1997 | US5656621 Steroids useful as anti-cancer and anti-obesity agents |
| 04/16/1996 | US5508275 Lipid-selective antioxidants and their preparation and use |
| 02/28/1996 | CN1117735A Steroids for treating menopausal complaints |
| 12/28/1995 | WO1995035301A1 Cationic amphiphiles |
| 11/22/1995 | EP0682672A1 Steroids for treating menopausal complaints |
| 10/24/1995 | US5461041 Progestogen-only contraceptive |
| 09/06/1995 | EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 08/23/1995 | EP0510167B1 Novel steroidal organic substance crystallization method and compounds thereby obtained |
| 05/23/1995 | US5418228 Contraceptive regimen |
| 04/18/1995 | US5407926 Ophthalmic composition |
| 03/15/1995 | EP0643070A1 Steroid intermediates and process for their preparation |
| 03/08/1995 | EP0440752B1 Method for the preparation of 3-desoxy-4-ene steroids |
| 12/06/1994 | US5371078 Angiostatic steroids and methods and compositions for controlling ocular hypertension |
| 11/09/1994 | EP0623140A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 09/14/1994 | EP0614463A1 Angiostatic steroids |
| 08/18/1994 | WO1994018224A1 Steroids for treating menopausal complaints |
| 08/18/1994 | CA2155532A1 Steroids for treating menopausal complaints |
| 07/12/1994 | US5329050 Process for the preparation of substituted indanones, and their use |
| 06/07/1994 | US5318987 Used for prophylaxis and treats coronary, circulatory and vascular diseases |
| 05/26/1994 | WO1994011385A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 05/03/1994 | CA1329195C Steroids useful as anti-cancer and anti-obesity agents |
| 12/23/1993 | WO1993025569A1 Oestradiol prodrugs |
| 11/30/1993 | US5266712 Process for crystallizing the organic substances from steroidal origin and the thus obtained compounds |
| 11/16/1993 | US5262408 Low estrogen oral contraceptives |
| 11/10/1993 | EP0568879A1 Process for the preparation of substituted indanones and their use |
| 11/09/1993 | CA1324126C Stereoisomerically pure 17.alpha.-ethynyl-estra-2-en-17.beta.-ol and the 17.beta.-esters thereof, methods of preparation and uses |
| 10/29/1993 | CA2094980A1 Process for the preparation of substituted indanones, and their use |
| 09/02/1993 | WO1993010141A3 Angiostatic steroids |
| 09/01/1993 | CN1075722A Steroid, preparing processing, intermediate and application |
| 08/17/1993 | US5236913 Powerful gestagenic properties and only slight androgenic side effects |
| 07/08/1993 | WO1993013123A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 05/27/1993 | WO1993010141A2 Angiostatic steroids |
| 05/27/1993 | CA2425846A1 Angiostatic steroids |
| 05/18/1993 | CA1317932C 9.,11.beta.-substituted and 11.beta.-substituted estranes |
| 03/23/1993 | CA1314871C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| 03/23/1993 | CA1314870C Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents |
| 03/23/1993 | CA1314869C 11-methylene-oestr-15-enes, processes for their preparation, and pharmaceutical compositions |
| 02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
| 12/29/1992 | US5175154 Antiobesity, antidiabetic, antilipemic, anticholesterol agents |
| 12/15/1992 | CA1311469C --lactone derivatives and process of preparing same |
| 10/28/1992 | EP0510167A1 Novel steroidal organic substance crystallization method and compounds thereby obtained. |
| 10/20/1992 | US5157031 Method for prophylaxis of obesity |
| 08/18/1992 | US5140106 Process for the production of 3-deoxy-4-ene steroids |
| 07/08/1992 | CN1062465A Progestagen-only contraceptive |
| 07/08/1992 | CN1062464A Contraceptive regimen |
| 07/01/1992 | CN1062290A Low estrogen oral contraceptives |
| 06/24/1992 | EP0491443A1 Progestagen-only contraceptive |
| 06/24/1992 | EP0491438A1 Contraceptive regimen |